why choose us

First received: October 23, 2023

Clinical Trial: A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Study Status: Completed

Recruit Status: RECRUITING

Condition: Sjogren's Syndrome

Study Type: INTERVENTIONAL


Official Title: A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-severe Systemic Disease Ac

Brief Summary: Primary Objective:To evaluate the effect of dazodalibep on systemic manifestations of Sjögren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity.Secondary Objectives:To evaluate the effect of dazodalibep on patient reported outcomes (PROs) in participants with SS.To evaluate the safety and tolerability of dazodalibep in participants with SS

Read more